PDS Biotechnology Corp
PDSB· Nasdaq
Filed Nov 7, 2019 · 10-Q · 38 days after period end · 0001140361-19-019968
| Metric | Q3 2019 | Q3 2018 | Q3 2017 | Q3 2016 |
|---|---|---|---|---|
| Net Income | -$5.75M | -$711.21K | -$11.28M | -$10.76M |
| EPS Diluted | -$1.10 | -$0.21 | — | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
PDS Biotechnology Corp · CIK 1472091 · Engraved from SEC EDGAR
ended Sep 30, 2019 · filed Nov 7, 2019 · 38 d after period end